We are live on
!
Find out more
CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Est. Return
64.75%
This Fund
S&P 500
This Quarter
Est. Return
+0.98%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.4B
AUM Growth
-$202M
(-1.4%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
0.14%
Top 10 Holdings %
Top 10 Hldgs %
9.45%
Holding
521
New
56
Increased
102
Reduced
204
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$80.8M |
| 2 |
Teleflex
TFX
|
+$60.5M |
| 3 |
Dollar General
DG
|
+$59.8M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$55.5M |
| 5 |
CERN
Cerner Corp
CERN
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$88.1M |
| 2 |
Xcel Energy
XEL
|
+$75.6M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$69.2M |
| 4 |
Merit Medical Systems
MMSI
|
+$62.5M |
| 5 |
Ameriprise Financial
AMP
|
+$61.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Industrials | 16.58% |
| 3 | Healthcare | 16.32% |
| 4 | Consumer Discretionary | 13.18% |
| 5 | Financials | 8.49% |
Similar funds
GAM
CCI
SWM
LCM
HCMNY
BII
HCM
DBC
Carillon Tower Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, Carillon Tower Advisers held 521 positions worth $14.4B, down 1.4% from $14.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
Carillon Tower Advisers's Q3 2019 filing shows 56 new, 102 increased, 204 reduced and 55 closed positions. Its largest new stake was Fidelity National Information Services: 608,629 shares worth $80.8M. The largest sale was Edwards Lifesciences, an estimated $88.1M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.
- Carillon Tower Advisers's largest Q3 2019 buy was Fidelity National Information Services: 608,629 shares worth $80.8M.
- Carillon Tower Advisers added most to Teleflex in Q3 2019, an estimated $60.5M increase.
- Carillon Tower Advisers's biggest Q3 2019 reduction was Edwards Lifesciences, cutting an estimated $88.1M.
- Carillon Tower Advisers fully exited Worldpay, Inc. in Q3 2019, selling an estimated $69.2M.
- Carillon Tower Advisers's ten largest holdings make up 9.5% of its $14.4B portfolio in Q3 2019.
- Carillon Tower Advisers opened 56 new positions and closed 55 in Q3 2019.
- Carillon Tower Advisers's portfolio value fell 1.4% quarter-over-quarter to $14.4B.
Based on Carillon Tower Advisers's 13F filing for Q3 2019, filed 5 Nov 2019.